Distribution and clinical significance of human papillomavirus subtypes in Shenzhen city, People's Republic of China

International Journal of Gynecological Cancer

Volumn 18, Issue 2, 2008, Pages 295-299

  Dai, Y ^a   Huang, Y S ^b   Tang, M ^b   Lv, X P ^a   Li, T Y ^a   Yin, Y B ^b  

^a JINAN UNIVERSITY   (China)

^b CHONGQING MEDICAL UNIVERSITY   (China)

Author keywords

Genotyping; Human; Papillomavirus; Viral

Indexed keywords

WART VIRUS VACCINE;

ADULT; ADVANCED CANCER; ARTICLE; CANCER STAGING; CHINA; CONDYLOMA ACUMINATUM; DOT HYBRIDIZATION; FEMALE; GENITAL TRACT INFECTION; GENOTYPE; HIGH RISK PATIENT; HUMAN; INFECTION RATE; MAJOR CLINICAL STUDY; MALE; PAPILLOMA VIRUS; POLYMERASE CHAIN REACTION; PREVALENCE; PRIORITY JOURNAL; UTERINE CERVIX CANCER; VIRUS TYPING;

ADULT; ALPHAPAPILLOMAVIRUS; CHINA; CONDYLOMATA ACUMINATA; FEMALE; HUMANS; MALE; MIDDLE AGED; PAPILLOMAVIRUS INFECTIONS; UTERINE CERVICAL NEOPLASMS;

EID: 40549143106     PISSN: 1048891X     EISSN: 15251438     Source Type: Journal    
DOI: 10.1111/j.1525-1438.2007.01024.x     Document Type: Article

References (23)

1. Bernard HU. Phylogeny and taxonomy of papillomaviruses. In : Campo MS, eds. Papillomavirus research: from natural history to vaccines and beyond. Norfolk : Caister Academic Press, 2006 : 11 7.
2. Bernard HU. The clinical importance of the nomenclature, volution and taxonomy of human papillomaviruses. J Clin Virol 2005 32 (Suppl. 1 1 6.
3. Munoz N, Bosch FX, de Sanjose S et al. Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med 2003 348 : 518 27.
4. Einstein MH, Goldberg GL. Human papillomavirus and cervical neoplasia. Cancer Invest 2002 20 : 1080 5.
5. Coutlee F, Gravitt P, Richardson H et al. Nonisotopic detection and typing of human papillomavirus DNA in genital samples by the line blot assay. The Canadian Women's HIV study group. Clin Microbiol 1999 37 : 1852 7.
6. Kawasaki ES, Chehab FF. Analysis of gene sequences by hybridization of PCR-amplified DNA to covalently bound oligonucleotide probes. The reverse dot blot method. Methods Mol Biol 1994 28 : 225 36.
7. Pham TH, Nguyen TH, Herrero R et al. Human papillomavirus infection among women in South and North Vietnam. Int J Cancer 2003 104 : 213 20.
8. Sukvirach S, Smith JS, Tunsakul S et al. Population-based human papillomavirus prevalence in Lampang and Songkla, Thailand. J Infect Dis 2003 187 : 1246 56.
9. Pagliusi S. World Health Organization. Human papillomavirus infection and cervical cancer. Available at : http://www.who.int/vaccine_research/diseases/ hpv/en/. Accessed October 26, 2006.
10. Parkin DM, Whelan SL, Ferlay J, Thomas DB, Teppo L. Cancer incidence in five continents, Vol. 8. IARC Scientific Publications No. 155. Lyon : IARC Press, 2002.
11. Yang L, Huangpu XM, Zhang SW et al. Changes of mortality rate for cervical cancer during 1970's and 1990's periods in China. Acta Acad Med Sin 2003 25 : 386 90.
12. Yang L, Parkin DM, Li L, Chen Y. Time trends in cancer mortality in China: 1987-1999. Int J Cancer 2003 106 : 771 83.
13. Dai M, Bao YP, Li N et al. Human papillomavirus infection in Shanxi Province, People's Republic of China: a population-based study. Br J Cancer 2006 95 : 96 101.
14. Li LK, Dai M, Clifford GM et al. Human papillomavirus infection in Shenyang City, People's Republic of China: a population-based study. Br J Cancer 2006 95 : 1593 7.
15. Qiu AD, Wu EQ, Yu XH et al. HPV prevalence, E6 sequence variation and physical state of HPV16 isolates from patients with cervical cancer in Sichuan, China. Gynecol Oncol 2007 104 : 77 85.
16. Wu Y, Chen Y, Li L, Yu G, Zhang Y, He Y. Associations of high-risk HPV types and viral load with cervical cancer in China. J Clin Virol 2006 35 : 264 9.
17. Burd EM. Human papillomavirus and cervical cancer. Clin Microbiol Rev 2003 16 : 1 17.
18. Schellekens MC, Dijkman A, Aziz MF et al. Prevalence of single and multiple HPV types in cervical carcinomas in Jakarta, Indonesia. Gynecol Oncol 2004 93 : 49 53.
19. Munoz N, Bosch FX, Castellsague X et al. Against which human papillomavirus types shall we vaccinate and screen? The international perspective. Int J Cancer 2004 111 : 278 85.
20. Cuschieri KS, Cubie HA, Whitley MW et al. Multiple high risk HPV infections are common in cervical neoplasia and young women in a cervical screening population. J Clin Pathol 2004 57 : 68 72.
21. Munoz N, Castellsague X, de Gonzalez AB, Gissmann L. HPV in the etiology of human cancer. Vaccine 2006 24 (Suppl. 3 S1 10.
22. Meijer CJ, Snijders PJ, Castle PE. Clinical utility of HPV genotyping. Gynecol Oncol 2006 103 : 12 7.
23. Saslow D, Castle PE, Cox JT et al. American Cancer Society Guideline for human papillomavirus (HPV) vaccine use to prevent cervical cancer and its precursors. CA Cancer J Clin 2007 57 : 7 28.